In this insightful episode of The Innovators & Investors Podcast, host Kristian Marquez sits down with Jenna Anderson, CEO of KiHealth, to explore groundbreaking advancements in preventive diagnostics.

Jenna shares how KiHealth is revolutionizing healthcare with the first portfolio of tests designed to detect diseases like diabetes years before symptoms appear by measuring novel biomarkers at the cellular level.

They discuss the challenges of transforming university-based innovations from Yale into scalable, affordable liquid biopsy tests that empower consumers to take control of their metabolic health.

Jenna dives deep into the current healthcare system’s reactive nature and the urgent need for proactive, early disease detection to combat chronic conditions such as diabetes, pancreatic cancer, and neurodegenerative diseases.

The conversation also highlights the complexities of navigating regulatory approval, insurance coverage, and educating stakeholders across doctors, payers, consumers, and pharmaceutical manufacturers.

Jenna offers invaluable advice for entrepreneurs working with university IP and reflects on her personal journey motivated by her mother’s battle with Alzheimer’s disease.

This episode is a must-listen for anyone interested in the intersection of healthcare innovation, diagnostics, and the future of preventive medicine.

Learn more about Jenna's work at https://www.kihealth.com/

Connect with Jenna on LinkedIn at https://www.linkedin.com/in/jennamonsanderson/

Think you'd be a great guest on the show? Apply at https://finstratmgmt.com/innovators-investors-podcast/

Want to learn more about Kristian Marquez's work? Check out his website at https://finstratmgmt.com